The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.
Published: 01 Aug 2024
Citation: Ünal S, Yağcı AM. The investigation of janus kinase 2 and calreticulin mutations in patients with essential thrombocytosis. J Curr Hematol Oncol Res. 2024;2(3):54-58.
Published: 01 Aug 2024
Citation: Keklik M, Mert Yüce M, Akyol G, Mandacı Şanlı N, Çelik S, Eser B. Causes of acquired isolated neutropenia in adulthood: a single center study.J Curr Hematol Oncol Res. 2024;2(3):59-62.
Published: 01 Aug 2024
Citation: Akyol G, Keklik M, Kaynar L, Ünal A. Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation. J Curr Hematol Oncol Res. 2024;2(3):63-66.
Published: 01 Aug 2024
Citation: Çelik S, Erkurt MA, Sarıcı A. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience. J Curr Hematol Oncol Res. 2024;2(3):67-71.
Published: 01 Aug 2024
Citation: Tan T, Ağırbaşlı M. Current status and potential future of PAI-1 inhibitors. J Curr Hematol Oncol Res. 2024;2(3): 72-75.
Published: 01 Aug 2024
Citation: Aksöz Z. A case report of relapsed/refractory primary central nervous system lymphoma. J Curr Hematol Oncol Res. 2024; 2(3):76-78.
Published: 30 Aug 2023
Citation: Barış Iİ, Büyükbayram H. ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status. J Curr Hematol Oncol Res. 2023;1(3):54-58.
Published: 30 Aug 2023
Citation: Fidan K. Chronic lymphocytic leukemia. J Curr Hematol Oncol Res. 2023;1(3):59-67.
Published: 26 Feb 2023
Citation: Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4